MedPath

Effect of Therapeutic Phlebotomies on the Triglycerides Concentration in Patients With Hypertriglyceridemia and Hyperferritinemia

Not Applicable
Completed
Conditions
Hyperferritinemia
Hypertriglyceridemia
Interventions
Behavioral: Dietary and lifestyle counseling.
Procedure: Phlebotomy
Registration Number
NCT02526121
Lead Sponsor
Instituto Aragones de Ciencias de la Salud
Brief Summary

The purpose of this study is to evaluate the effect of iron depletion with phlebotomies on blood triglyceride concentration, in subjects with hypertriglyceridemia and iron overload, compared with a dietary intervention alone.

All subjects in this study will follow dietary and lifestyle counseling in a period of 3 months.

A randomized group will receive phlebotomies every 3 weeks in this period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Hyperferritinemia: > 300µgr/L for male and >200µgr/L for female.
  • Hypertriglyceridemia: > 200 mg/dL in two determinations after at least ten hours of fasting and lipid-lowering diet.
Exclusion Criteria
  • Contraindications for phlebotomy: poor venous access, previous intolerance (hypotension or apprehension), heart disease, anemia.
  • Subjects suffering from acute or chronic disease, including liver disease, diabetes, cancer, kidney disease or uncontrolled thyroid disease.
  • Elevated C reactive protein (CRP) as a parameter of inflammation (>10mg/L).
  • Alcohol intake: over 30 gr. per day for men and 25 gr. per day for women.
  • Lipid lowering drugs use.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietary and lifestyle counseling.Dietary and lifestyle counseling.-
Phlebotomy associated with dietary and lifestyle counselingPhlebotomy-
Phlebotomy associated with dietary and lifestyle counselingDietary and lifestyle counseling.-
Primary Outcome Measures
NameTimeMethod
Triglycerides concentrationThree months before
Secondary Outcome Measures
NameTimeMethod
Iron parametersThree months before

Ferritin level: \>300 µgr/L in men and \>200 µgr/L in women

Trial Locations

Locations (1)

Hospital Universitario Miguel Servet

🇪🇸

Zaragoza, Spain

© Copyright 2025. All Rights Reserved by MedPath